Outcomes of staged hepatectomies for liver malignancy

Table 1 Contraindications of portal vain embolization

	Contraindications
	Absolute	Relative
Portal vein embolization	Overt clinical portal vein hypertension	Mild portal vein hypertension
	Extensive invasion of portal vein precluding safe catheter manipulation	Tumor extension to the FLR
		Biliary dilatation of the FLR
		Extrahepatic metastatic disease
	Complete lobar portal vein occlusion
		Uncorrectable coagulopathy
		Renal insufficiency

FLR: Future liver remnant.

Table 2 Comparison between associated liver partition and portal vein ligation for staged hepatectomy and conventional two-staged hepatectomy

Complication	ALPPS	Conventional TSH
Major morbidity (Clavien-Dindo IIIA)	40%	33%
Bile leaks	24%	5.8%
Sepsis	20%	0%
Re exploration	28%	2.9%
Liver-related mortality	12%	5.8%

ALPPS: Associated liver partition and portal vein ligation for staged hepatectomy; TSH: Two-staged hepatectomy.